VANGUARD GROUP INC - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 37 filers reported holding THE ONCOLOGY INSTITUTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q3 2023$2,461,248
+153.7%
1,758,034
-0.3%
0.00%
Q2 2023$969,975
-26.4%
1,762,950
-9.3%
0.00%
Q1 2023$1,317,528
-58.7%
1,943,543
+0.6%
0.00%
Q4 2022$3,188,799
-63.0%
1,932,606
+3.9%
0.00%
Q3 2022$8,613,000
+8.0%
1,860,242
+18.1%
0.00%
Q2 2022$7,972,000
+33.4%
1,575,435
+87.9%
0.00%
Q1 2022$5,977,000
+38.6%
838,321
+89.5%
0.00%
Q4 2021$4,313,000442,3440.00%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q2 2022
NameSharesValueWeighting ↓
Parian Global Management LP 183,828$930,0004.26%
Velan Capital Investment Management LP 600,000$3,036,0003.08%
Triatomic Management LP 365,679$1,850,0001.70%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,383,099$17,118,0000.35%
Redmile Group, LLC 1,736,116$8,785,0000.34%
Saba Capital Management, L.P. 367,292$1,858,0000.02%
FMR LLC 12,000,078$60,720,0000.01%
BANK OF AMERICA CORP /DE/ 6,251$31,0000.00%
WELLS FARGO & COMPANY/MN 470$2,0000.00%
NORTHERN TRUST CORP 143,921$729,0000.00%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders